SELL Biocon Ltd — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)14 Nov 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.
Biocon shares fall 2.06% in early trade
NewsGoogle News·13 Aug · 4w ago
2 other SEBI-registered advisors have active long-term SELL calls on this stock
Advisor consensus · same horizon·15 Jul · 2mo ago
Buy, Sell Or Hold: IndiGo, Maruti Suzuki, Biocon, LIC, Hindustan Copper, Bharat Dynamics — Ask Profit
NewsNdtv-Profit·2 Sept · 6d ago
Buy, Sell Or Hold: Mahindra & Mahindra, Coforge, TVS Motor, Biocon And Divi's Labs — Ask Profit
NewsNdtv-Profit·30 Aug · 1w ago
Buy, Sell Or Hold: Mazagon Dock, HAL, Biocon, Suzlon And Tata Motors PV — Ask Profit
NewsNdtv-Profit·18 Aug · 3w ago
Biocon sees double-digit biosimilars growth continuing, targets mid-20% margins
NewsCnbc-Tv18·8 Sept · today
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
NewsEt-Markets·8 Sept · today
Biocon shares gain after bagging 10-year contract in Brazil for Breast Cancer treatment drug
NewsCnbc-Tv18·8 Sept · today
Biocon has secured a 10-year supply contract for Pertuzumab in Brazil under the country's Productive Development Partnership (PDP) program. This agreement grants exclusive access to Brazil's public he
BSE · Company Update·8 Sept · today
Biocon Limited has secured a 10-year supply contract for Pertuzumab in Brazil, as announced in a press release dated September 08, 2026.
NSE · Press Release·8 Sept · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.